Without a trace
Medical tracer technologies are routinely used to detect cancer, but emerging nanotechnologies have the ability to treat as well as trace. What do we need to do to accelerate their adoption?
Mar 1, 2022
Medical tracer technologies are routinely used to detect cancer, but emerging nanotechnologies have the ability to treat as well as trace. What do we need to do to accelerate their adoption?
If you’re in #genomics, you know the challenges of complex biological data.
@Biomatics_uk have launched a new service offering experienced & flexible resources to support your project.
From academia to consultancy services & genomics delivery, learn more:
https://www.lifescienceintegrates.com/data-solutions-in-genomics/
The no. of people diagnosed with #cancer could increase by 18% in 2040. Prevention, detection, diagnosis & treatments are improving, but there's still lots to do. Ahead of #WorldCancerDay tomorrow, watch ‘the Big C’ panel discussion from #PharmaIntegrates
https://player.vimeo.com/video/772550592?h=6a6380832a&dnt=1&app_id=122963
Last #February, we held our first #PharmaSustainabilityIntegrates with @ukCPI, @ABPI_UK & @UniStrathclyde
As a unique forum for leaders in #Pharma & #policy to discuss how to take #COP26 forward, it’s a chance to look at how far we’ve come in a year:
https://www.lifescienceintegrates.com/101-days-from-cop26-life-sciences-lead-the-way-to-decarbonisation-at-pharma-sustainability-integrates/
Medical tracer technologies are routinely used to detect cancer, but emerging nanotechnologies have the ability to treat as well as trace. What do we need to do to accelerate their adoption?